Antihypertensive effect of Chunghyul-dan(Qingxue-dan) on stage 1 hypertensive patients with stroke

중풍환자 1기 고혈압에 청혈단(淸血丹)의 항고혈압 효과

  • Kim, Lee-Dong (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Lee, Sang-Ho (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Kim, Eun-Ju (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Kim, Tai-Hun (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Park, Young-Min (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Jung, Dong-Won (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Shin, Won-Jun (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Jung, Woo-Sang (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Bae, Hyung-Sup (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University) ;
  • Yun, Sang-Pil (Department of Cardiovascular and Neurologic Diseases(Stroke Center) College of Oriental Medicine, Kyung-Hee University)
  • 김이동 (경희대학교 한의과대학 2 내과학 교실) ;
  • 이상호 (경희대학교 한의과대학 2 내과학 교실) ;
  • 김은주 (경희대학교 한의과대학 2 내과학 교실) ;
  • 김태훈 (경희대학교 한의과대학 2 내과학 교실) ;
  • 박영민 (경희대학교 한의과대학 2 내과학 교실) ;
  • 정동원 (경희대학교 한의과대학 2 내과학 교실) ;
  • 신원준 (경희대학교 한의과대학 2 내과학 교실) ;
  • 정우상 (경희대학교 한의과대학 2 내과학 교실) ;
  • 배형섭 (경희대학교 한의과대학 2 내과학 교실) ;
  • 윤상필 (경희대학교 한의과대학 2 내과학 교실)
  • Published : 2004.06.30

Abstract

Background and Purpose : Hypertension is one of the modifiable risk factors for stroke. Lowering blood pressure is a primary or secondary preventative measure for stroke. This study aims to assess the efficacy of Chunghyul-dan(Qingxue-dan) in stage 1 hypertensive patients who have suffered a stroke by 24 hour ambulatory blood pressure monitoring(24ABPM). Subjects& Methods : We enrolled 40 hospitalized stroke patients with stage 1 hypertension and divided them into 2 groups by stratified randomization; group A took 1200mg of Chunghyul-dan(Qingxue-dan) at 8:00 a.m. for two weeks without changing herbal medicine, and group B was the control group. 28 patients were included in the final analysis(15 in group A. 13 in group B). Blood pressure is monitored from 8:00 am to 7:30 am every 30 minutes for 24 hours. Blood pressure was monitored two times at baseline and again two weeks later. We used 3 parameters for evaluating the efficacy of Chunghyul-dan(Qingxue-dan); The first parameter is change from baseline to two weeks later in blood pressure and pulse rate. The second parameter is the trough/peak ratio(TPR) and smoothness index(SI). The third parameter is antihypertensive rate by antihypertensive efficacy guideline. Results : There is no significant difference in the baseline assessment hetween the two groups. Systolic blood pressure $(141.37{\pm}8.96\;mmHg\;vs\;132.28{\pm}9.46\;mmHg)$ decreased after two weeks of 1200mg(P=0.03) intake of Chunghyul-dan(Qingxue-dan). Systolic TPR and SI was 0.87 and 1.04 in group A. Antihypertensive rate was higher in group A. Conclusion: These results suggest that 1200mg doses of Clunghyul-dan(Qingxue-dan) is an effective antihypertensive agent on stage 1 hypertension patients who have suffered a stroke.

Keywords

References

  1. Urology v.165 Voiding and sexual dysfunction after cerebrovascular accidents Marinkovic, S.;Badlani, G.
  2. 2002 사망원인 통계연보 통계청
  3. Stroke v.32 Estimates of prevalence of acute stroke impairments and disability in multiethnic population Lawrence, E.S.;Coshall, C.;Dundas, R.;Stewart, J.;Rudd, A.G.;Howard, R.(et al.)
  4. Cerebrovasc Dis. v.16 Blood pressure and lipid lowering in the prevention of stroke: a note to neurologists Pierre Amarence
  5. J Hypertens v.12 no.SUP.10 Blood pressure, antihypertensive treatment and stroke risk MacMahon, S.;Rodgers, A.
  6. BMJ v.324 Use of ramipril in preventing stroke: double blind randomized trial Bosch, J.;Yusuf, S.;Pogue, J.;Sleight, P.;Lonn, E.;Rangoonwala, B.(et al.)
  7. Biol Pharm Bull. v.25 no.11 Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase Kim, Y.S.;Jung, E.A.;Shin, J.E.;Chung, J.C.;Yang, H.K.;Kim, N.J.;Cho, K.H.;Bae, H.S.;Moon, S.K.;Kim, D.H.
  8. Life Sci. v.71 no.18 Hwangryun-Hae-Dok-tan (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats Hwang, Y.S.;Shin, C.Y.;Huh, Y.;Ryu, J.H.
  9. Pharmacol Res. v.41 no.2 Effects of San'oshashin-to on the antioxidative mechanism in spontaneous familial hypercholesterolaemic rabbits Iijima, O.T.;Takeda, H.;Matsumiya, T.
  10. 대한한방내과학회지 v.24 no.3 淸血丹이 고지혈증 환자의 혈청지질에 미치는 영향 정기현;최요섭;김이동;김정렬;정우상;문상관;조기호
  11. 대한한의학회지 v.24 no.3 淸血丹의 임상적인 부작용에 대한 연구 조기호;정우상;박성욱;문상관;김영석;배형섭
  12. 2004 대한한방내과학회 춘계학술대회 논문집 淸血丹이 중풍환자의 1기 고혈압에 미치는 영향-적정용량을 위한 예비적 연구- 윤상필;김이동;이상호;김은주;박영민;정우상(등)
  13. JAMA v.246 Blood pressure after stroke Wallace, J.D.;Levy, L.L.
  14. JAMA v.289 The seventh report of the joint national committe on prevention. detection. evaluation. and treatment of high blood pressure-the JNC report The national high blood pressure education program coordingating committe
  15. J Hyperten v.21 2003 European society of hypertension-european society of cardiology guidelines for the management of arterial hypertension Guidelines Committe
  16. J Hypertens v.13 Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure methodological aspects Omboni, S.;Parati, G.;Zanchetti, A.;Mancia, G.
  17. High Blood Press v.6 Beyond trough:peak ratio : a new index of the smoothness of the antihypertensive effect of a drug Rizzoni, D.;Castellano, M.;Muiesan, M.L.;Porteri, E.;Agabiti-Rosei, E.
  18. J Hypertens v.16 The smoothness index: a new, reproducible and clinically relevant measure of the homogenity of the blood pressure reduction with treatment for hypertension Parati, G.;Omboni, S.;Rizzoni, D.;Agabiti-Rosei, E.;Mancia, G.
  19. 고혈압 v.6 no.1 본태성 고혈압 환자에서 Alacepril의 항고혈압효과를 평가하기 위한 임상 시험 김명아;조주희;김상현;김원배;김철호
  20. Lancet. v.358 Randomized trial of perindopril based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack Progress Collaborative Group
  21. J Hypertens v.18 no.6 The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group Farsang, C.;Garcia-Puig, J.;Niegowska, J.;Baiz, A.Q.;Vrijens, F.;Bortman, G.
  22. J Hypertens v.8 Isolated systolic hypertension in the elderly Staessen, J.;Amery, A.;Fagard, R.
  23. Am Heart J v.138 Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile Kannel, W.B.
  24. Arch Intern Med. v.160 no.21 Prognosis of isolated systolic and isolated diastolic hypertension as assessed by selfmeasurement of blood pressure at home: the Ohasama study Hozawa, A.;Ohkubo, T.;Nagai, K.;Kikuya, M.;Matsubara, M.;Tsuji, I.(et al.)
  25. JAMA v.265 no.24 Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) SHEP Cooperative Research Group
  26. Am J Cardiol. v.82 no.9B Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial Staessen, J.A.;Thijs, L.;Gasowski, J.;Cells, H.;Fagard, R.H.
  27. Biol Pharm Bull. v.23 no.6 Effects of 9 kampo medicines clinically used in hypertension on hemodynamic changes induced by theophylline in rats Sanae, F.;Komatsu, Y.;Amagaya, S.;Chisaki, K.;Hayashi, H.
  28. 대한한방내과학회지 v.24 no.2 黃連解毒湯이 家兎의 血管緊張調節에 미치는 영향 권오율;남창규;김호현;정찬길;성현제
  29. Biol Pharm Bull. v.24 no.10 Effects of san' o sashin-to and the constiuent herbal medicines on theophylline-induced increase in arterial blood pressure on rats Sanae, F.;Komatsu, Y.;Chisaki, K.;Kido, T.;Isige, A.;Hayashi, H.
  30. Blood Press Monit. v.6 no.1 The importance of 24-h blood pressure control Neutel, J.M.
  31. J Hypertens v.19 no.4 The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment Rizzoni, D.;Muiesan, M.L.;Salvetti, M.;Castellano, M.;Bettoni, G.;Monteduro, C.(et al.)
  32. Proposed guidelines for the clinical evaluation of antihypertensive drug products(Draft) FDA division of cardi-renal drug products
  33. J Hypertens v.16 Role of trough to peak efficacy in the evaluation of antihypertensive treatment Meredith, P.A.
  34. Am J Hypertens v.9 no.7 Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists Zannad, F.;Matzinger, A.;Larche, J.
  35. Hypertension v.42 no.12 Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Chobanian, A.V.;Bakris, G.L.;Black, H.R.;Cushman, W.C.;Green, L.A.;Izzo, J.L. Jr.(et al.)
  36. Arch Intern Med. v.150 no.9 The effect of prescribed daily dose frequency on patient medication compliance Eisen, S.A.;Miller, D.K.;Woodward, R.S.;Spitznagel, E.;Przybeck, T.R.